A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1222-1229

  Pardo, J ^a   Perez Galan P ^a   Gamen, S ^a   Marzo, I ^a   Monleon I ^a   Kaspar, A A ^a   Susin S A ^a   Kroemer, G ^a   Krensky, A M ^a   Naval, J ^a   Anel, A ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CERAMIDE; GRANULYSIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXOCYTOSIS; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035421688     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1222     Document Type: Article

References (54)

1. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
2. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
3. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation
4. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases
5. Cell-mediated cytotoxicity and cell death receptors
6. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones
7. Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation
8. Granzyme A initiates an alternative pathway for granule-mediated apoptosis
9. The isolation and sequence of a novel gene from human functional T cell line
10. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins
11. Granulysin-induced apoptosis, I. Involvement of at least two distinct pathways
12. An antimicrobial activity of cytolytic T cells mediated by granulysin
13. A distinct pathway of cell-mediated apoptosis initiated by granulysin
14. Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family
15. Molecular characterization of mitochondrial apoptosis-inducing factor
16. Genomic structure and alternative splicing of 519, a gene expressed late after T cell activation
17. Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemias
18. Induction of apoptotic DNA fragmentation and cell death by natural ceramide
19. CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells
20. Inhibition of human caspases by peptide-based and macromolecular inhibitors
21. Sensibility of drug screening with panels of human tumor cell lines using microculture tetrazolium assay
22. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis
23. Detection of tumor necrosis factor induced nuclear damage with p-phenylenediamine
24. Fluorescent staining of nuclei and amyloid substance: Two useful properties of p-phenylenediamine
25. Two CD95 (APO-1/Fas) signaling pathways
26. Mitochondrial control of cell death
27. Death receptors: Signaling and modulation
28. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates apoptotic protease cascade
29. Target protease specificity of the viral serpin CrmA: Analysis of five caspases
30. The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2-related proteins
31. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
32. Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA
33. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
34. +, cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis
35. Plasma membrane potential during thymocyte apoptosis
36. m loss, caspase-9 activity, and apoptosis in Jurkat cells
37. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
38. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis
39. Comparative modeling of amoebapores and granulysin based on the NK-lysin structure: Structurally and functional implications
40. Lipid membrane binding of NK-lysin
41. 2+-trigger site
42. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals
43. Stimulation of phosphatidylinositol turnover is a key event for Fas-dependent, activation-induced apoptosis in human T lymphocytes
44. Apoptotic cell death and CPP32 activation induced by calcium ionophore at low concentrations and their prevention by nerve growth factor in PC12 cells
45. Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells
46. Caspase-9 can be activated without proteolytic processing
47. Two distinct pathways leading to nuclear apoptosis
48. Ceramide in apoptosis: Does it really matter?
49. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition
50. Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide-signaling pathway
51. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology
52. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
53. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane
54. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin